AAAAAA

   
Results: 1-25 | 26-50 | 51-75 | 76-81
Results: 1-25/81

Authors: HICKSON I FAIRBAIRN LJ CHINNASAMY N LASHFORD LS THATCHER N MARGISON GP DEXTER TM RAFFERTY JA
Citation: I. Hickson et al., CHEMOPROTECTIVE GENE-TRANSFER - I - TRANSDUCTION OF HUMAN HEMATOPOIETIC PROGENITORS WITH O-6-BENZYLGUANINE-RESISTANT O-6-ALKYLGUANINE-DNA ALKYLTRANSFERASE ATTENUATES THE TOXIC EFFECTS OF O-6-ALKYLATING AGENTS IN-VITRO, Gene therapy, 5(6), 1998, pp. 835-841

Authors: CHINNASAMY N RAFFERTY JA HICKSON I LASHFORD LS LONGHURST SJ THATCHER N MARGISON GP DEXTER TM FAIRBAIRN LJ
Citation: N. Chinnasamy et al., CHEMOPROTECTIVE GENE-TRANSFER-II - MULTILINEAGE IN-VIVO PROTECTION OFHEMATOPOIESIS AGAINST THE EFFECTS OF AN ANTITUMOR AGENT BY EXPRESSIONOF A MUTANT HUMAN O-6-ALKYLGUANINE-DNA ALKYLTRANSFERASE, Gene therapy, 5(6), 1998, pp. 842-847

Authors: VONLANTHEN S HEIGHWAY J TSCHAN MP BORNER MM ALTERMATT HJ KAPPELER A TOBLER A FEY MF THATCHER N YARBROUGH WG BETTICHER D
Citation: S. Vonlanthen et al., EXPRESSION OF P16INK4A P16-ALPHA AND P19ARF/P16-BETA IS FREQUENTLY ALTERED IN NONSMALL CELL LUNG-CANCER AND CORRELATES WITH P53 OVEREXPRESSION/, Oncogene, 17(21), 1998, pp. 2779-2785

Authors: MIDDLETON M THATCHER N
Citation: M. Middleton et N. Thatcher, G-CSF AND GM-CSF, International journal of antimicrobial agents, 10(2), 1998, pp. 91-93

Authors: THATCHER N RANSON M ANDERSON H BURT P DAVIDSON N NICOLSON M FALK S CARMICHAEL J WASHINGTON T JEYNES A
Citation: N. Thatcher et al., PHASE-III STUDY OF PACLITAXEL (TAXOL(R)) (T) VERSUS BEST SUPPORTIVE CARE (BSC) IN INOPERABLE NONSMALL CELL LUNG-CANCER (NSCLC), Annals of oncology, 9, 1998, pp. 4-4

Authors: KEILHOLZ U CONRADT C LEGHA SS KHAYAT D SCHEIBENBOGEN C THATCHER N GOEY SH GORE M DORVAL T HANCOCK B PUNT CJA DUMMER R AVRIL MF BROCKER EB BENHAMMOUDA A EGGERMONT AMM PRITSCH M
Citation: U. Keilholz et al., RESULTS OF INTERLEUKIN-2-BASED TREATMENT IN ADVANCED MELANOMA - A CASE RECORD-BASED ANALYSIS OF 631 PATIENTS, Journal of clinical oncology, 16(9), 1998, pp. 2921-2929

Authors: STEWARD WP VONPAWEL J GATZEMEIER U WOLL P THATCHER N KOSCHEL G CLANCY L VERWEIJ J DEWIT R PFEIFER W FENNELLY J VONEIFF M FRISCH J
Citation: Wp. Steward et al., EFFECTS OF GRANULOCYTE-MACROPHAGE COLONY-STIMULATING FACTOR AND DOSE INTENSIFICATION OF V-ICE CHEMOTHERAPY IN SMALL-CELL LUNG-CANCER - A PROSPECTIVE RANDOMIZED STUDY OF 300 PATIENTS, Journal of clinical oncology, 16(2), 1998, pp. 642-650

Authors: THATCHER N
Citation: N. Thatcher, MANAGEMENT OF CHEMOTHERAPY-INDUCED ANEMIA IN SOLID TUMORS, Seminars in oncology, 25(3), 1998, pp. 23-26

Authors: THATCHER N LEE SM WOLL PJ MIDDLETON M ANDERSON H BURT P STOUT R
Citation: N. Thatcher et al., DOSE INTENSITY IN SMALL-CELL LUNG-CANCER, Seminars in oncology, 25(2), 1998, pp. 12-18

Authors: MIDDLETON MR LUNN JM MORRIS C RUSTIN G WEDGE SR BRAMPTON MH LIND MJ LEE SM NEWELL DR BLEEHEN NM NEWLANDS ES CALVERT AH MARGISON GP THATCHER N
Citation: Mr. Middleton et al., O-6-METHYLGUANINE-DNA METHYLTRANSFERASE IN PRETREATMENT TUMOR-BIOPSIES AS A PREDICTOR OF RESPONSE TO TEMOZOLOMIDE IN MELANOMA, British Journal of Cancer, 78(9), 1998, pp. 1199-1202

Authors: JAYSON GC MIDDLETON M LEE SM ASHCROFT L THATCHER N
Citation: Gc. Jayson et al., A RANDOMIZED PHASE-II TRIAL OF INTERLEUKIN-2 AND INTERLEUKIN 2-INTERFERON-ALPHA IN ADVANCED RENAL-CANCER, British Journal of Cancer, 78(3), 1998, pp. 366-369

Authors: ANDERSON H MERCER V RUSSELL L HABBOUBI N THATCHER N
Citation: H. Anderson et al., A PHASE-III RANDOMIZED STUDY OF CARBOPLATIN AND AMIFOSTINE (A) VS CARBOPLATIN AND G-CSF IN PATIENTS WITH INOPERABLE NON-SMALL-CELL LUNG-CANCER (NSCLC), European journal of cancer, 33, 1997, pp. 55-55

Authors: THATCHER N HOPWOOD P ANDERSON H
Citation: N. Thatcher et al., IMPROVING QUALITY-OF-LIFE IN PATIENTS WITH NONSMALL CELL LUNG-CANCER - RESEARCH EXPERIENCE WITH GEMCITABINE, European journal of cancer, 33, 1997, pp. 8-13

Authors: MILTON ID BANNER SJ INCE PG PIGGOTT NH FRAY AE THATCHER N HORNE CHW SHAW PJ
Citation: Id. Milton et al., EXPRESSION OF THE GLIAL GLUTAMATE TRANSPORTER EAAT2 IN THE HUMAN CNS - AN IMMUNOHISTOCHEMICAL STUDY, Molecular brain research, 52(1), 1997, pp. 17-31

Authors: RANSON MR JAYSON G PERKINS S ANDERSON H THATCHER N
Citation: Mr. Ranson et al., SINGLE-AGENT PACLITAXEL IN ADVANCED NONSMALL CELL LUNG-CANCER - SINGLE-CENTER PHASE-II STUDY USING A 3-HOUR ADMINISTRATION SCHEDULE, Seminars in oncology, 24(4), 1997, pp. 6-9

Authors: THATCHER N JAYSON G BRADLEY B RANSON M ANDERSON H
Citation: N. Thatcher et al., GEMCITABINE - SYMPTOMATIC BENEFIT IN ADVANCED NONSMALL CELL LUNG-CANCER, Seminars in oncology, 24(3), 1997, pp. 86-812

Authors: PRIOR M THATCHER N MORRIS P REESE T BACHELARD H
Citation: M. Prior et al., MK801 ONLY PARTIALLY BLOCKS THE EFFECTS OF ISCHEMIA - AN MRS STUDY, Journal of neurochemistry, 69, 1997, pp. 146-146

Authors: BETTICHER DC WHITE GRM VONLANTHEN S LIU X KAPPELER A ALTERMATT HJ THATCHER N HEIGHWAY J
Citation: Dc. Betticher et al., G(1) CONTROL GENE STATUS IS FREQUENTLY ALTERED IN RESECTABLE NONSMALLCELL LUNG-CANCER, International journal of cancer, 74(5), 1997, pp. 556-562

Authors: WOLL PJ BASSER R LECHEVALIER T DRINGS P MANGA GP ADENIS A SEYMOUR L SMITH F THATCHER N
Citation: Pj. Woll et al., PHASE-II TRIAL OF RALTITREXED (TOMUDEX) IN ADVANCED SMALL-CELL LUNG-CANCER, British Journal of Cancer, 76(2), 1997, pp. 264-265

Authors: BETTICHER DC HEIGHWAY J THATCHER N HASLETON PS
Citation: Dc. Betticher et al., ABNORMAL EXPRESSION OF CCND1 AND RB1 IN RESECTION MARGIN EPITHELIA OFLUNG-CANCER PATIENTS, British Journal of Cancer, 75(12), 1997, pp. 1761-1768

Authors: GIRLING DJ THATCHER N CLARK PI STEPHENS RJ
Citation: Dj. Girling et al., INCREASING THE DOSE INTENSITY OF CHEMOTHERAPY BY MEANS OF GRANULOCYTE-COLONY-STIMULATING FACTOR (G-CSF) SUPPORT IN THE TREATMENT OF SMALL-CELL LUNG-CANCER (SCLC), European journal of cancer, 32A(7), 1996, pp. 1263-1263

Authors: MARTIN C LUND B ANDERSON H THATCHER N
Citation: C. Martin et al., GEMCITABINE - ONCE-WEEKLY SCHEDULE ACTIVE AND BETTER TOLERATED THAN TWICE-WEEKLY SCHEDULE, Anti-cancer drugs, 7(3), 1996, pp. 351-357

Authors: LEE SM REID H ELDER RH THATCHER N MARGISON GP
Citation: Sm. Lee et al., INTERCELLULAR AND INTRACELLULAR HETEROGENEITY OF O-6-ALKYLGUANINE-DNAALKYLTRANSFERASE EXPRESSION IN HUMAN BRAIN-TUMORS - POSSIBLE SIGNIFICANCE IN NITROSOUREA THERAPY, Carcinogenesis, 17(4), 1996, pp. 637-641

Authors: GIRLING DJ THATCHER N CLARK PI HOPWOOD P TWIDDY S STEPHENS RJ BAILEY AJ MACHIN D BLEEHEN NM BOLGER JJ CONNOLLY CK HASLETON PS MACBETH FR MOGHISSI K SAUNDERS MI WHITE RJ ALCOCK S BURT H CROSSLEY E DECKER E ENGLISH J FOSTER G HANNIGAN K HERON D HUTCHINSON J LOMAX L MERCER V PAGE S ROTHWELL T STAINES K TAYLORNEAL P TURNBALL V AXFORD AT EARL HM GLAHOLM J FALK SJ GRAHAM JD JONES DK COOMBES RC EPSTEIN RJ HANHAM I LOWDELL CP NEWLANDS E SMITH DB COOKSON JB ANDERSON H GRIBBIN HR SINCLAIR DJM CARMICHAEL J CHAN SYT JOHNSTON IDA MORGAN SA DUNN KS MANIFOLD IH RADSTONE DJ LAMONT A ROBINSON ACR BISSETT D NICOLSON MC TANG OT SINNAMON DG VARGHESE G BIBBY RJ OREILLY JF BATH JCJ BREDIN CP STEWART SJ WHILLIS D WILTSHIRE CR MCILLMURRAY MB BOND MG WARDMAN AG BOZZINO JM FERGUSON GC MACMILLAN CH SUGDEN EM TALBOT DC QUIGLEY IG WEATHERSTONE RM VEALE D OREGAN PF
Citation: Dj. Girling et al., COMPARISON OF ORAL ETOPOSIDE AND STANDARD INTRAVENOUS MULTIDRUG CHEMOTHERAPY FOR SMALL-CELL LUNG-CANCER - A STOPPED MULTICENTER RANDOMIZED TRIAL, Lancet, 348(9027), 1996, pp. 563-566

Authors: HENRY DH THATCHER N
Citation: Dh. Henry et N. Thatcher, PATIENT SELECTION AND PREDICTING RESPONSE TO RECOMBINANT-HUMAN-ERYTHROPOIETIN IN ANEMIC CANCER-PATIENTS, Seminars in hematology, 33(1), 1996, pp. 2-5
Risultati: 1-25 | 26-50 | 51-75 | 76-81